- November 8, 2011Kyorin Pharmaceutical and Daiichi Sankyo Brasil Reach Agreement in Brazil for Activities Related to the Development and Marketing of Imidafenacin
- April 5, 2011Release of "Uritos® OD Tablets 0.1mg" a Drug for Overactive Bladder
- February 24, 2011Kyorin signed a License Agreement with Almirall on COPD Therapeutic Agent "Aclidinium Bromide" for Japan Territory
- February 21, 2011KYORIN Group's Participation in Environmental Hygiene
- November 12, 2010Approval Received for Orally Disintegrating Tablet of imidafenacin (INN), a Drug for Overactive Bladder
- November 8, 2010Extension of License Rights Regarding KRP-203
- June 8, 2010RELEASE OF "MUCODYNE® DS50%"
- January 18, 2010MARKETING APPROVAL FOR "MUCODYNE® DS50%"
